Literature DB >> 18032119

A rapid, sensitive and selective liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry method for determination of fenretinide (4-HPR) in plasma.

James I Lee1, Vu T Nguyen, Mei-Ling Chen, Peter C Adamson.   

Abstract

A simple and sensitive liquid chromatography/tandem mass spectrometry (LC-MS/MS) method using an atmospheric pressure chemical ionization source (APCI) for the quantification of fenretinide (4-HPR) in mouse plasma was developed and validated. After a simple protein precipitation of plasma sample by acetonitrile, 4-HPR was analyzed by LC-APCI-MS/MS. High-performance liquid chromatography (HPLC) separation was conducted on a Hypurity C18 column (50mmx2.1mm, 5microm) with a flow rate 0.60mL/min using a gradient mobile phase comprised of 0.05% formic acid in water (A) and methanol (B), and a run time of 4.5min. The elimination of a tedious sample preparation process and a shorter run time substantially reduced total analysis time. The method was linear over the range 0.5-100ng/mL, with r>0.998. The intra- and inter-assay precisions were 1.4-9.2% and 5.1-8.2%, respectively, and the intra- and inter-assay accuracies were 93.9-98.6% and 92.7-95.3%, respectively. The absolute recoveries were 90.3% (1.5ng/mL), 97.0% (7.5ng/mL) and 92.1% (75.0ng/mL) for 4-HPR, and 99.1% for the internal standard (150ng/mL). The analytical method had excellent sensitivity using a small sample volume (30microL) with the lower limit of quantification (LLOQ) 0.5ng/mL. This method is robust and has been successfully employed in a pharmacokinetic study of 4-HPR in a mouse xenograft model of neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032119      PMCID: PMC2259245          DOI: 10.1016/j.jchromb.2007.10.044

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  25 in total

Review 1.  Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry.

Authors:  Paul J Taylor
Journal:  Clin Biochem       Date:  2005-04       Impact factor: 3.281

Review 2.  Chemoprevention of breast cancer with fenretinide.

Authors:  U Veronesi; G De Palo; A Costa; F Formelli; A Decensi
Journal:  IARC Sci Publ       Date:  1996

3.  Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations.

Authors:  B K Matuszewski; M L Constanzer; C M Chavez-Eng
Journal:  Anal Chem       Date:  1998-03-01       Impact factor: 6.986

4.  Long-term effects of fenretinide on retinal function.

Authors:  A Decensi; V Fontana; M Fioretto; G Rondanina; R Torrisi; M A Orengo; A Costa
Journal:  Eur J Cancer       Date:  1997-01       Impact factor: 9.162

Review 5.  All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi).

Authors:  S Sacchi; D Russo; G Avvisati; G Dastoli; M Lazzarino; P G Pelicci; M R Bonora; G Visani; C Grassi; I Iacona; L Luzzi; P Vanzanelli
Journal:  Haematologica       Date:  1997 Jan-Feb       Impact factor: 9.941

6.  Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point.

Authors:  A Decensi; S Bruno; M Costantini; R Torrisi; A Curotto; B Gatteschi; G Nicolò; A Polizzi; M Perloff; W F Malone
Journal:  J Natl Cancer Inst       Date:  1994-01-19       Impact factor: 13.506

7.  Chemopreventive potential of fumaric acid, N-acetylcysteine, N-(4-hydroxyphenyl) retinamide and beta-carotene for tobacco-nitrosamine-induced lung tumors in A/J mice.

Authors:  C C Conaway; D Jiao; G J Kelloff; V E Steele; A Rivenson; F L Chung
Journal:  Cancer Lett       Date:  1998-02-13       Impact factor: 8.679

8.  Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide.

Authors:  K C Lewis; J F Hochadel
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

9.  Phase II trial of fenretinide in advanced renal carcinoma.

Authors:  Ulka Vaishampayan; Lance K Heilbrun; Ralph E Parchment; Vikash Jain; James Zwiebel; Ramesh R Boinpally; Patricia LoRusso; Maha Hussain
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

10.  Effects of N-(4-hydroxyphenyl)retinamide supplementation on vitamin A metabolism.

Authors:  K C Lewis; L A Zech; J M Phang
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

View more
  3 in total

1.  Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.

Authors:  Richard A Graves; Grace A Ledet; Elena Y Glotser; Demaurian M Mitchner; Levon A Bostanian; Tarun K Mandal
Journal:  Eur J Pharm Sci       Date:  2015-04-28       Impact factor: 4.384

2.  Analysis of fenretinide and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics.

Authors:  Hwang Eui Cho; H Kang Min
Journal:  J Pharm Biomed Anal       Date:  2016-09-29       Impact factor: 3.935

3.  Optimization and validation of a reversed-phase high performance liquid chromatography method for the measurement of bovine liver methylmalonyl-coenzyme a mutase activity.

Authors:  Bazoumana Ouattara; Mélissa Duplessis; Christiane L Girard
Journal:  BMC Biochem       Date:  2013-10-16       Impact factor: 4.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.